pentoxifylline has been researched along with Psoriasis in 8 studies
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy of sulfasalazine and pentoxifylline, which have TNF antagonizing and anti-proliferative action in the treatment of psoriasis." | 9.15 | Sulfasalazine and pentoxifylline in psoriasis: a possible safe alternative. ( Abdel-Halim, M; Azzam, O; Bassiouny, DA; el-Darouti, M; el-Hadidi, H; el-Hanafy, G; el-Mofty, M; el-Ramly, A; Fawzy, M; Rasheed, H; Zaki, NS, 2011) |
| "Psoriasis is a chronic skin inflammatory auto-immune disorder." | 5.72 | Cyclosporine and Pentoxifylline laden tailored niosomes for the effective management of psoriasis: In-vitro optimization, Ex-vivo and animal study. ( Bhardwaj, P; Gupta, R; Pandey, S; Ramchandra Patil, P; Tripathi, P, 2022) |
| "To assess the efficacy of sulfasalazine and pentoxifylline, which have TNF antagonizing and anti-proliferative action in the treatment of psoriasis." | 5.15 | Sulfasalazine and pentoxifylline in psoriasis: a possible safe alternative. ( Abdel-Halim, M; Azzam, O; Bassiouny, DA; el-Darouti, M; el-Hadidi, H; el-Hanafy, G; el-Mofty, M; el-Ramly, A; Fawzy, M; Rasheed, H; Zaki, NS, 2011) |
| "Psoriasis is a chronic skin inflammatory auto-immune disorder." | 1.72 | Cyclosporine and Pentoxifylline laden tailored niosomes for the effective management of psoriasis: In-vitro optimization, Ex-vivo and animal study. ( Bhardwaj, P; Gupta, R; Pandey, S; Ramchandra Patil, P; Tripathi, P, 2022) |
| "Psoriasis is characterized by abnormal cell proliferation, inflammation and increased biosynthesis of various cytokines." | 1.29 | Antiproliferative effect of pentoxifylline on psoriatic and normal epidermis. In vitro and in vivo studies. ( Cohen, S; Eitan, A; Gilhar, A; Grossman, N; Kahanovicz, S; Reuveni, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bhardwaj, P | 1 |
| Tripathi, P | 1 |
| Pandey, S | 1 |
| Gupta, R | 1 |
| Ramchandra Patil, P | 1 |
| Ghate, VM | 1 |
| Kodoth, AK | 1 |
| Shah, A | 1 |
| Vishalakshi, B | 1 |
| Lewis, SA | 1 |
| el-Mofty, M | 1 |
| el-Darouti, M | 1 |
| Rasheed, H | 1 |
| Bassiouny, DA | 1 |
| Abdel-Halim, M | 1 |
| Zaki, NS | 1 |
| el-Hanafy, G | 1 |
| el-Hadidi, H | 1 |
| Azzam, O | 1 |
| el-Ramly, A | 1 |
| Fawzy, M | 1 |
| Grashin, RA | 1 |
| Antonov, VG | 1 |
| Karpishchenko, AI | 1 |
| Khaĭrutdinov, VR | 1 |
| Rakhmatov, AB | 1 |
| Ibragimov, ShI | 1 |
| Omulecki, A | 1 |
| Broniarczyk-Dyła, G | 1 |
| Zak-Prelich, M | 1 |
| Choczaj-Kukuła, A | 1 |
| Gilhar, A | 1 |
| Grossman, N | 1 |
| Kahanovicz, S | 1 |
| Reuveni, H | 1 |
| Cohen, S | 1 |
| Eitan, A | 1 |
| Merino, E | 1 |
| Torrux, D | 1 |
| Boix, V | 1 |
| Portilla, J | 1 |
2 trials available for pentoxifylline and Psoriasis
| Article | Year |
|---|---|
Sulfasalazine and pentoxifylline in psoriasis: a possible safe alternative.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; | 2011 |
Is pentoxifylline effective in the treatment of psoriasis?
Topics: Humans; Pentoxifylline; Phosphodiesterase Inhibitors; Placebos; Psoriasis; Tumor Necrosis Factor-alp | 1996 |
6 other studies available for pentoxifylline and Psoriasis
| Article | Year |
|---|---|
Cyclosporine and Pentoxifylline laden tailored niosomes for the effective management of psoriasis: In-vitro optimization, Ex-vivo and animal study.
Topics: Animals; Cholesterol; Cyclosporine; Imiquimod; Liposomes; Mice; Particle Size; Pentoxifylline; Polys | 2022 |
Colloidal nanostructured lipid carriers of pentoxifylline produced by microwave irradiation ameliorates imiquimod-induced psoriasis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colloids; Drug Carriers; Imiquimod; Lipids; Male; | 2019 |
[The free radical oxidation and antioxidant defense systems as indicators of the activity of keratinocytic proliferation in psoriasis].
Topics: Antioxidants; Cell Proliferation; Cells, Cultured; Dioxanes; Free Radicals; Humans; Keratinocytes; L | 2010 |
[Clinical and treatment characteristics of psoriasis patients with carbohydrate metabolic disorders].
Topics: Adult; Aged; Blood Glucose; Carbohydrates; Chronic Disease; Diabetes Mellitus; Drug Therapy, Combina | 1983 |
Antiproliferative effect of pentoxifylline on psoriatic and normal epidermis. In vitro and in vivo studies.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinogens; E | 1996 |
[Improvement of severe psoriasis in a HIV(+) patient].
Topics: Adult; Female; HIV Infections; Humans; Pentoxifylline; Psoriasis; Recurrence; Stomatitis, Aphthous; | 2000 |